ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Management of nonsevere (MVA >1.5 m2) rheumatic mitral stenosis

Management of nonsevere (MVA >1.5 m2) rheumatic mitral stenosis
All patients with rheumatic mitral stenosis should receive routine follow-up and medical management including drug therapy (eg, diuretic) for heart failure, management of atrial fibrillation, and anticoagulation as indicated.

MVA: mitral valve area; PAWP: pulmonary artery wedge pressure; PMBC: percutaneous mitral balloon commissurotomy; MR: mitral regurgitation; LA: left atrial; MS: mitral stenosis.

* PAWP is generally measured by pulmonary artery catheter. Mean mitral valve gradient is most commonly measured by Doppler echocardiography.

¶ The favorability of mitral valve morphology is based upon valvular and subvalvular features associated with successful PMBC (effective reduction of severity of MS without inducing/worsening MR). Refer to UpToDate content on scoring systems to assess the favorability of mitral valve morphology and other criteria for PMBC.
Graphic 139030 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟